COVID-19 Vaccine effectiveness among Healthcare Workers during the Omicron Period in the country of Georgia, January – June 2022

Caleb L Ward,Madelyn Yiseth Rojas Castro,Giorgi Chakhunashvili,Nazibrola Chitadze,Iris Finci,Richard Pebody,Esther Kissling,Mark A Katz,Lia Sanodze

DOI: https://doi.org/10.1101/2024.09.19.24314033

2024-09-22

Abstract:Introduction Understanding COVID-19 vaccine effectiveness (VE) in healthcare workers (HCWs) is critical to inform vaccination policies. We measured COVID-19 VE against laboratory-confirmed symptomatic infection in HCWs in the country of Georgia from January – June 2022, during a period of Omicron circulation. Methods We conducted a cohort study of HCWs in six hospitals in Georgia. HCWs were enrolled in early 2021. Participants completed weekly symptom questionnaires. Symptomatic HCWs were tested by RT-PCR and/or rapid antigen test (RAT). Participants were also routinely tested, at varying frequencies during the study period, for SARS-CoV-2 by RT-PCR or RAT, regardless of symptoms. Serology was collected quarterly throughout the study and tested by electrochemiluminescence immunoassay for SARS-CoV-2 antibodies. We estimated absolute and relative VE of a first booster dose compared to a primary vaccine series as (1-hazard ratio)*100 using Cox proportional hazards models. Results Among 1253 HCWs, 141 (11%) received a primary vaccine series (PVS) and a first booster, 855 (68%) received PVS only, and 248 (20%) were unvaccinated. Most boosters were BNT162b2 (Comirnaty original monovalent) vaccine (90%) and BIBP-CorV vaccine (Sinopharm) (9%). Most PVS were BNT162b2 vaccine (68%) and BIBP-CorV vaccine (24%). Absolute VE for a first booster was 40% (95% Confidence Interval (CI) -56 – 77) at 7– 29 days following vaccination, -9% (95% CI -104 – 42) at 30 – 59 days, and -46% (95% CI -156 – 17) at ≥ 60 days. Relative VE of first booster dose compared to PVS was 58% (95% CI 1 – 82) at 7– 29 days following vaccination, 21% (95% CI -33 – 54) at 30 – 59 days, and -9% (95% CI -82 – 34) at ≥ 60 days. Conclusion In Georgia, first booster dose VE against symptomatic SARS-CoV-2 infection among HCWs was moderately effective but waned very quickly during Omicron. Increased efforts to vaccinate priority groups in Georgia, such as healthcare workers, prior to periods of anticipated high COVID-19 incidence are essential.

Infectious Diseases (except HIV/AIDS)

What problem does this paper attempt to address?

This paper aims to explore the effectiveness of COVID-19 vaccine booster shots among healthcare workers in Georgia during the Omicron variant outbreak. Specifically, the study evaluates the vaccine effectiveness (VE) of healthcare workers after laboratory-confirmed symptomatic infection through a cohort study method. The study found that within the first 29 days after receiving the first booster shot, the absolute effectiveness against symptomatic infection was 40%, but this effect rapidly diminished, dropping to -9% after 30 to 59 days, and further decreasing to -46% after 60 days. In terms of relative effectiveness, compared to only completing the primary immunization series, it increased by 58% within 7 to 29 days after receiving the booster shot, but then also rapidly declined. The study emphasizes the importance of enhancing vaccination for priority groups such as healthcare workers before periods of high anticipated COVID-19 outbreaks.